Bio-Techne Corp
NASDAQ:TECH

Watchlist Manager
Bio-Techne Corp Logo
Bio-Techne Corp
NASDAQ:TECH
Watchlist
Price: 73.03 USD 0.4% Market Closed
Market Cap: 11.6B USD
Have any thoughts about
Bio-Techne Corp?
Write Note

Bio-Techne Corp
Investor Relations

Bio-Techne Corp. began its journey with a clear focus: to bridge the gap between biological research and practical applications, a mission that it continues to pursue with zeal. At its core, Bio-Techne operates as a pioneer in the production and distribution of biotechnology products, catering to the needs of the scientific community across the globe. The company specializes in providing essential tools for life sciences research, including proteins, antibodies, and reagents, empowering researchers to explore and innovate in fields ranging from cancer biology to neuroscience. These offerings are developed with meticulous care and a deep understanding of the scientific process, which positions Bio-Techne as a trusted ally to laboratories and research institutions worldwide.

The financial heartbeat of Bio-Techne lies in its diverse portfolio, which extends into clinical diagnostics and genomics, segments that are critical in an era of personalized medicine and rapid technological advancement in healthcare. The company's revenue streams are robust, driven by a strategic blend of direct sales and collaborations with major pharmaceutical and biotech companies. Furthermore, Bio-Techne smartly leverages its acquisitions to fortify its market position, enhancing its capabilities and expanding its product lines. This agility and foresight not only enable Bio-Techne to sustain its growth trajectory but also to continually meet the ever-evolving demands of a fast-paced, innovation-driven industry.

Show more

Earnings Calls

Show Transcript
Previous
Next
Loading

Management

Mr. Kim Kelderman
CEO, President & Director
No Bio Available
Mr. James T. Hippel CPA
Executive VP of Finance & CFO
No Bio Available
Mr. Shane Bohnen
Senior VP, General Counsel, Corporate Secretary & Chief Sustainability Officer
No Bio Available
Mr. William A. Geist
President of Protein Sciences Segment
No Bio Available
Dr. Matthew F. McManus M.D., MBA, Ph.D.
President of Diagnostics & Genomics
No Bio Available
Dr. Gary J. Latham Ph.D.
VP & CTO
No Bio Available
Mr. David Clair C.F.A.
Senior Director of Investor Relations & Corporate Development
No Bio Available
Mr. Gerry Andros
Vice President of Sales and Marketing
No Bio Available
Mr. Martin Wirtz
Senior Vice President of Strategy & Corporate Development
No Bio Available
Ms. Cheryl Bethune
Senior VP & Chief Human Resources Officer
No Bio Available

Contacts

Address
MINNESOTA
Minneapolis
614 McKinley Pl NE
Contacts
+16123798854.0
www.bio-techne.com